+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations



Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations



Haemophilia 22(3): 440-445



Haemophilia B is caused by a heterogeneous spectrum of mutations. Mutation characterization is important in genetic counselling, prenatal diagnosis and to predict risk of inhibitor development. To study the mutation spectrum, frequency of unique recurrent mutations, genotype-phenotype association and inhibitor development in a population-based study of the complete Swedish haemophilia B population. The study included, facilitated by centralized DNA diagnostics, the complete registered Swedish haemophilia B population (113 families: 47 severe, 22 moderate and 44 mild), each represented by a single patient. Mutation characterization was performed by conventional sequencing of all exons and haplotyping by genotyping of single nucleotide variants and microsatellites. A mutation was found in every family: eight had large deletions, three had small deletions (<10 base pair) and 102 had single base pair substitutions (69 missense, 26 nonsense, four splice site and three promoter). Ten novel mutations were found and were predicted to be deleterious. Sixteen mutations (one total gene deletion, 14 substitutions and one acceptor splice site) were present in more than one family. Of the single nucleotide mutations (37/102), 36% arose at CpG sites. Haplotyping of families with identical mutations and present analyses showed that the frequency of unique mutations was at least 65%. Inhibitors developed in 9/47 (19%) patients with severe haemophilia B. The spectrum of haemophilia B mutations reveals at least 65% of the families carry a unique mutation, but with more inhibitor patients than reported internationally, probably as a result of many 'null' mutations.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058366013

Download citation: RISBibTeXText

PMID: 26612714

DOI: 10.1111/hae.12854


Related references

Analysis of factor VIII gene inversion mutations in 166 unrelated haemophilia A families: frequency and utility in genetic counselling. Haemophilia 2(1): 18-23, 1996

Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?. Haemophilia 14(4): 723-728, 2008

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. Journal of Biosciences 34(3): 415-422, 2009

Low frequency of hMSH2 mutations in Swedish HNPCC families. International Journal of Cancer 74(1): 134-137, 1997

Mutation analysis in 32 families with haemophilia A. British Journal of Haematology 121(Supplement 1): 64, 2003

Characterization of the frequency of delta F508 mutation and CF haplotypes in Swedish families. Clinical Genetics 39(3): 238-239, 1991

Mutation analysis in F9 gene of 17 families with haemophilia B from Iran. Haemophilia 10(6): 751-755, 2004

Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing. Haemophilia 22(5): E427-E434, 2017

Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101(2): 276-284, 1998

Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations. Human Genetics 109(5): 503-511, 2001

High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families. Human Genetics 102(5): 549-556, 1998

Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations. Haemophilia 20(6): 859-865, 2015

Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations. Haemostasis 30(5): 268-279, 2001